Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Redditors Think Tempus AI (TEM) Still Has 10X Potential
Balancing openness and control: Cross-border health data and AI governance in China
Vaughan Nelson Investment Management L.P. Purchases Shares of 10,355 AstraZeneca PLC $AZNCF - Stock Observer
Robbins Farley Invests $4.96 Million in AstraZeneca PLC $AZNCF - Daily Political
AstraZeneca announces major financial investment to bring medical breakthroughs to patients' bedsides - Yahoo News Canada
3 UK Stocks Trading Below Fair Value On Cash Flow Views
5 Best Weight Loss Drug Stocks to Buy in 2026
Biotech Stocks Facing FDA Decision In July 2026
6,851 Shares in AstraZeneca PLC $AZNCF Acquired by Town & Country Bank & Trust CO dba First Bankers Trust CO - Stock Observer
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020
Purpose Unlimited Inc. Takes Position in Astrazeneca Plc $AZN - Zolmax
The top 3 FTSE shares for beginner investors to consider buying in 2026
3 UK Stocks Trading Below Cash Flow Value
Astrazeneca Plc $AZN is Mengis Capital Management Inc.'s 5th Largest Position - Zolmax
Rockefeller Capital Management L.P. Sells 147,931 Shares of Astrazeneca Plc $AZN - Stock Observer
S Harris Financial Group LLC Acquires Shares of 7,355 Astrazeneca Plc $AZN - Daily Political
3 UK AI Healthcare Stocks With Revenue Growth And Funding Risk
4,532 Shares in Astrazeneca Plc $AZN Acquired by Keenan LLC - Daily Political
Larry Mathis Financial Planning LLC Purchases Shares of 5,770 Astrazeneca Plc $AZN - Daily Political
AstraZeneca (LSE:AZN) Stock Could Be 20.2% Below Fair Value After Recent Pullback
India could be on the radar for AstraZeneca's oral GLP-1 drug: MD
Deutsche Bank Remains a Hold on Novo Nordisk (0QIU)
Compound Planning Inc. Purchases 9,655 Shares of Astrazeneca Plc $AZN
Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note
Castle Hook Partners LP Buys New Holdings in Astrazeneca Plc $AZN
AZN: New Approvals And AI Use Will Support Future Repricing
AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials
Fred Alger Management LLC Buys 1,263,721 Shares of Astrazeneca Plc $AZN - Markets Daily
Astrazeneca Plc $AZN Shares Acquired by National Bank of Canada FI - Stock Observer
Crawford Investment Counsel Inc. Decreases Position in Astrazeneca Plc $AZN - Stock Observer
Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial
Exploiting androgen receptor agonism as a treatment strategy in estrogen receptor-positive metastatic breast cancer
Oddo BHF Asset Management Sas Invests $35.06 Million in Astrazeneca Plc $AZN - Daily Political
Astrazeneca Plc (NYSE:AZN) Receives $205.33 Average Price Target from Brokerages - Daily Political
Healthcare of Ontario Pension Plan Trust Fund Acquires 9,897 Shares of Astrazeneca Plc $AZN - Daily Political
Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors
AstraZeneca (AZN) Faces Changes in Medicare Drug Price Negotiation Framework
Global Pharmaceutical Companies Boost US Manufacturing Amid Tariff Threats, ETPharma
AstraZeneca (AZN) Receives Priority Review for Ultomiris Treatment Application
Seven Mile Advisory Invests $738,000 in AstraZeneca PLC $AZNCF - Markets Daily
Mosaic Financial Group LLC Makes New Investment in AstraZeneca PLC $AZNCF
Mosaic Financial Group LLC Takes $913,000 Position in AstraZeneca PLC $AZNCF - Zolmax
AbCellera Biologics (ABCL) Stock Valuation After Adding Drug Development Expert Victor Sandor To The Board
Patterns of medication use across society from national primary care dispensing data
Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn's disease pathogenesis
Citi Initiates a Buy Rating on AstraZeneca (AZN)
Icon Wealth Advisors LLC Makes New $2.47 Million Investment in AstraZeneca PLC $AZNCF - Zolmax
FDA TRUQAP Approval Highlights AstraZeneca's Precision Oncology And Valuation Gap
Astrazeneca Plc $AZN is Foresight Global Investors Inc.'s Largest Position
Livet Wealth LLC Invests $651,000 in Astrazeneca Plc $AZN - Stock Observer
AstraZeneca : FDA Approves Truqap Combination For PTEN-Deficient Metastatic Prostate Cancer
Astrazeneca Plc $AZN is Trillium Asset Management LLC's 5th Largest Position - Daily Political
TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer | Morningstar
AstraZeneca (AZN) Receives FDA Approval for Truqap in Advanced Prostate Cancer
AstraZeneca's Drug Combination for Prostate Cancer Treatment Gets U.S. Approval | Morningstar
AstraZeneca (AZN) Secures U.S. Approval for Innovative Prostate Cancer Treatment
Roche reports FDA approval for prostate cancer companion diagnostic
Is AbCellera (ABCL) Using Boardroom Oncology Talent to Redefine Its Clinical Ambitions?
Truqap approved for PTEN-deficient metastatic hormone-sensitive prostate cancer
Vaughan David Investments LLC IL Invests $88.37 Million in AstraZeneca PLC $AZNCF - Markets Daily
If AI Healthcare Rewires Medicine These Three Stocks Could Lead
SmartHarvest Portfolios LLC Takes $751,000 Position in Astrazeneca Plc $AZN - Markets Daily
Woodley Farra Manion Portfolio Management Inc. Lowers Holdings in Astrazeneca Plc $AZN - Daily Political
Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancer
7,854 Shares in Astrazeneca Plc $AZN Bought by Hamel Associates Inc. - Markets Daily
Dorsey & Whitney Trust CO LLC Has $3.94 Million Stake in Astrazeneca Plc $AZN - Stock Observer
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer - The Economic Times
Type 2 Diabetes breakthrough: No more a jab - AstraZeneca's new oral GLP-1 delivers up to 10.5% weight loss
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
Opinion - Big Pharma lost in court - Congress must not bail it out
Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
Jim Cramer on AstraZeneca: "On Track to Hit the Ambitious Long-Term Financial Targets"
WINTON GROUP Ltd Invests $965,000 in Astrazeneca Plc $AZN - Daily Political
Is It Too Late To Reassess AstraZeneca (LSE:AZN) After Its Strong Multi‑Year Run?
"Brexit into Asia": British Capital's Shift Towards China
Encouraging trial results for AstraZeneca's new weight-loss pill - Japan Today
Astrazeneca (NYSE:AZN) Given "Buy" Rating at Jefferies Financial Group - Markets Daily
ADA: AZ's oral GLP-1 shows 'competitive efficacy' in phase 2
Jefferies Financial Group Reaffirms "Buy" Rating for AstraZeneca (LON:AZN) - Markets Daily
Deutsche Bank Aktiengesellschaft Reiterates "Sell" Rating for Astrazeneca (NYSE:AZN) - Stock Observer
GSK (GSK) Stock Slides 3% Following $10.6B Nuvalent Acquisition Deal
AstraZeneca's New Oral GLP-1 Aids Weight Loss and Lowers Blood Sugar - AOL
6,250 Shares in AstraZeneca PLC $AZNCF Acquired by Monetary Management Group Inc. - Daily Political
AstraZeneca's Elecoglipron Pill: Shattering Weight Loss Records with 10.5% Reduction, ETPharma
AstraZeneca's Obesity Pill Helps Patients Lose Weight in Midstage Trials | Morningstar
Ionis Appoints Hantson As Board Of Director, Effective Immediately
Quantum Corp (QMCO) Faces Pre-Market Decline of 3.1%
Geode Capital Management LLC Sells 17,227 Shares of Astrazeneca Plc $AZN - Stock Observer
Erste Asset Management GmbH Reduces Stock Position in Astrazeneca Plc $AZN - Stock Observer
O Shaughnessy Asset Management LLC Increases Stock Holdings in Astrazeneca Plc $AZN - Daily Political
Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants
The European respiratory society guideline for adult bronchiectasis 2025: summary and implementation guide for primary care
Sun Pharmaceutical Industries Ltd Option Chain & Strike Prices | IIFL Capital
Sun Pharmaceutical Industries Ltd Futures Share Price & Chart Today | IIFL Capital
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial
2 FTSE shares for beginners starting an ISA
Capital International Investors Has $2.55 Billion Stock Holdings in Astrazeneca Plc $AZN - Stock Observer
OneAscent Family Office LLC Makes New $613,000 Investment in Astrazeneca Plc $AZN - Stock Observer
Latest news
Show moreRussia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict
Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions
Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis
